Modifying Rap1-signalling by targeting Pde6δ is neuroprotective in models of Alzheimer's disease.
Dumbacher M, Van Dooren T, Princen K, De Witte K, Farinelli M, Lievens S, Tavernier J, Dehaen W, Wera S, Winderickx J, Allasia S, Kilonda A, Spieser S, Marchand A, Chaltin P, Hoogenraad CC, Griffioen G.
Dumbacher M, et al. Among authors: wera s.
Mol Neurodegener. 2018 Sep 26;13(1):50. doi: 10.1186/s13024-018-0283-3.
Mol Neurodegener. 2018.
PMID: 30257685
Free PMC article.